Immunic (IMUX) Financials

$12.19

$-0.55 (-4.32%)

As on 09-Sep-2026 16:00EDT

Market cap

$179 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.08	0.17	0.13	0.11	0.08	0.09
Gross Profit	-0.08	-0.17	-0.13	-0.11	-0.08	-0.09
Operating Expenses	117.85	103.23	98.05	99.22	119.49	91.67
Operating Profit (EBIT)	-117.88	-103.23	-98.05	-99.22	-119.49	-91.67
Other Income	--	--	--	--	-0.92	-1.28
Profit before Tax	-111.57	-97.17	-100.51	-93.61	-120.41	-92.95
Provision for Tax	--	--	-100.51	--	33.89	-0.15
Profit after Tax (Net Income)	-111.57	-97.17	-100.51	-93.61	-120.41	-92.79
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-120.41	-92.95

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	127.58	-6.67	18.43	28.93	113.68	127.12
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.33	0.11	0.26	0.64	0.99	0.58
Current Liabilities	31.26	30.62	22.18	24.73	13.08	11.40
Total Liabilities	190.43	24.05	40.87	54.30	127.75	139.10

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	1.34	1.18	1.54	1.77	1.89	34.11
Current Assets	157.83	22.87	39.33	52.53	125.86	104.99
Total Assets	190.43	24.05	40.87	54.30	127.75	139.10
Total Debt*	0.57	0.68	1.00	1.33	1.56	0.99
Net Current Assets	126.57	-7.75	17.16	27.81	112.79	93.59

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-85.81	-84.77	-70.83	-65.14	-83.23
Cash Flow from Investing Activities	--	-0.16	-0.26	9.46	-9.74	-0.07
Cash from Financing Activities	--	65.58	74.54	1.03	95.76	42.84
Net Cash Inflow / Outflow	--	--	--	--	20.88	-40.46

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-4.81	-8.07	-11.15	-20.97	-34.72	-35.24
Cash EPS ($)	--	-8.06	-11.13	-20.95	-34.69	-35.20
Adjusted Book Value ($)	--	--	2.04	6.48	32.78	48.27
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-7.13	-9.40	-15.87	-18.78	-31.61
Free Cash Flow per Share ($)	--	-7.14	-9.43	-15.94	-18.81	-31.63

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-1,445.58	-404.47	-128.67	-98.96	-64.47
ROE (%)	--	-1,653.15	-424.44	-131.28	-100.01	-64.91
ROA (%)	-79.93	-299.36	-211.22	-102.84	-90.24	-60.46
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	13,101.96	7,249.53
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-9.55	3.32	-7.37	-8.20	5.62	-87.18
Net Profit Growth (%)	-9.55	3.32	-7.37	22.25	-29.76	-110.81
EPS Growth (%)	50.67	0.28	0.47	0.40	0.01	-0.69
Book Value Growth (%)	16.97	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.07	-0.09	-0.07	-0.04	-0.27
Price / Book Value	1.57	-0.96	0.49	0.23	0.04	0.20
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.21	0.09	0.26	0.41	1.27	0.66
Close Price ($)	15.37	5.34	10.00	15.00	14.00	95.70
High Price ($)	92.05	13.90	21.10	31.70	145.00	282.14
Low Price ($)	5.06	5.06	9.70	9.45	11.10	69.60
Market Cap ($ Cr)	178.88	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-0.10	0.05	0.05	0.01	0.01
Short term debt to equity ratio	0.00	-0.07	0.04	0.02	0.01	0.00
Current Ratio	5.05	0.75	1.77	2.12	9.62	9.21
Quick Ratio	5.05	--	--	--	9.20	9.40
Interest Coverage	--	--	--	--	-83.11	-1,078.41

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	18,453.35	8,201.52	2,720.04
Payable days	--	19,549.57	17,642.39	15,432.64	18,452.24	15,467.26
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.